Michael Lobritz

Michael Lobritz, MD, PhD, serves as the VP and Global Head of the Infectious Diseases Therapeutic Area at Roche, where additional roles included Head of Infectious Diseases Early Development and Head of Antibiotics Early Development. Michael is also a member of the Board of Directors for both the AMR Action Fund and the AMR Industry Alliance. Previously, Michael worked at Massachusetts General Hospital as an Assistant in Medicine within the Division of Infectious Diseases and as an Infectious Disease Clinical and Research Fellow. Additionally, Michael held the position of Instructor at Harvard Medical School. Educational credentials include a Doctor of Medicine (MD) and a Doctor of Philosophy (PhD) in Molecular Biology and Microbiology, both obtained from Case Western Reserve University School of Medicine between 2001 and 2009.